logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Neuroprotective Therapy For Stroke And Ischemic Disease 1st Edition Paul A Lapchak

  • SKU: BELL-10304366
Neuroprotective Therapy For Stroke And Ischemic Disease 1st Edition Paul A Lapchak
$ 31.00 $ 45.00 (-31%)

4.3

88 reviews

Neuroprotective Therapy For Stroke And Ischemic Disease 1st Edition Paul A Lapchak instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 18.09 MB
Author: Paul A. Lapchak, John H. Zhang (eds.)
ISBN: 9783319453446, 9783319453453, 3319453440, 3319453459
Language: English
Year: 2017
Edition: 1

Product desciption

Neuroprotective Therapy For Stroke And Ischemic Disease 1st Edition Paul A Lapchak by Paul A. Lapchak, John H. Zhang (eds.) 9783319453446, 9783319453453, 3319453440, 3319453459 instant download after payment.

A critical and comprehensive look at current state-of-the-art scientific and translational research being conducted internationally, in academia and industry, to address new ways to provide effective treatment to victims of ischemic and hemorrhagic stroke and other ischemic diseases. Currently stroke can be successfully treated through the administration of a thrombolytic, but the therapeutic window is short and many patients are not able to receive treatment. Only about 30% of patients are "cured" by available treatments. In 5 sections, the proposed volume will explore historical and novel neuroprotection mechanisms and targets, new and combination therapies, as well as clinical trial design for some of the recent bench-side research.

Related Products